Allianz Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-48,200
Closed -$4.79M 2933
2019
Q3
$4.79M Sell
48,200
-22,400
-32% -$2.13M ﹤0.01% 1467
2019
Q2
$6.53M Sell
70,600
-3,700
-5% -$351K 0.01% 1377
2019
Q1
$7.01M Sell
74,300
-77,900
-51% -$6.81M 0.01% 1298
2018
Q4
$9.75M Sell
152,200
-48,600
-24% -$3.59M 0.01% 1117
2018
Q3
$18M Sell
200,800
-40,000
-17% -$3.53M 0.02% 957
2018
Q2
$19.1M Buy
240,800
+193,300
+407% +$16M 0.02% 907
2018
Q1
$4.24M Sell
47,500
-171,800
-78% -$16.5M ﹤0.01% 1606
2017
Q4
$22.9M Buy
219,300
+17,300
+9% +$1.95M 0.02% 919
2017
Q3
$29.5M Buy
202,000
+52,100
+35% +$7.1M 0.03% 778
2017
Q2
$19.5M Sell
149,900
-51,100
-25% -$6.26M 0.02% 982
2017
Q1
$25M Sell
201,000
-70,700
-26% -$8.46M 0.02% 879
2016
Q4
$31.4M Buy
271,700
+84,500
+45% +$9.41M 0.03% 783
2016
Q3
$19.6M Buy
187,200
+90,400
+93% +$9.78M 0.02% 986
2016
Q2
$9.55M Buy
96,800
+59,400
+159% +$6.14M 0.01% 1247
2016
Q1
$3.74M Sell
37,400
-3,300
-8% -$340K ﹤0.01% 1556
2015
Q4
$4.87M Buy
40,700
+17,700
+77% +$2.05M 0.01% 1359
2015
Q3
$2.49M Sell
23,000
-28,400
-55% -$3.52M ﹤0.01% 1523
2015
Q2
$5.95M Buy
51,400
+24,000
+88% +$2.74M 0.01% 1325
2015
Q1
$3.16M Sell
27,400
-7,500
-21% -$896K ﹤0.01% 1382
2014
Q4
$3.9M Buy
34,900
+22,900
+191% +$2.42M ﹤0.01% 1304
2014
Q3
$1.14M Buy
+12,000
New +$1.08M ﹤0.01% 1628

Other funds holding CELG

Allianz Asset Management's CELG Position: Q4 2019 in Review

Allianz Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 936,921 shares — an estimated $93M sold.

Allianz Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $305M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Allianz Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Allianz Asset Management sold 936,921 Celgene Corp shares in Q4 2019, an estimated $93M.
  • Allianz Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Allianz Asset Management's Celgene Corp position peaked at $305M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Allianz Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.